Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Public Citizen Criticizes FDA For Rejecting Blood Pressure Drugs Black Box Warnings April 14, 2015 Irvin Jackson Add Your Comments A prominent consumer watchdog group is taking the FDA to task for refusing to require stronger label warnings about the risks associated with the combined use of a number of popular hypertension drugs, like Benicar and Aliskiren. On April 3 the FDA notified Public Citizen that it was rejecting a 2012 petition to add black box warnings to hypertension drugs such as angiotensin-converting-enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARB) and Aliskiren, alerting doctors and patients not to use the drugs in combination. All of the drugs affect the body’s renin-angiotensin system (RAS), and the FDA acknowledges that chronic activation of the RAS can lead to constriction of blood cells, vascular injury, inflammation and other health risks. However, the agency said the drugs carry sufficient warnings. Learn More About Benicar Lawsuits Side Effects of Benicar May Cause Diarrhea, Villous Atrophy and Sprue-Like Enteropathy Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Benicar Lawsuits Side Effects of Benicar May Cause Diarrhea, Villous Atrophy and Sprue-Like Enteropathy Learn More SEE IF YOU QUALIFY FOR COMPENSATION “As with any drug therapy, pharmacologic inhibition of the RAS has certain risks,” the FDA rejection letter (PDF) states. “Consequently, the labeling for every ACE inhibitor, ARB, and aliskiren drug product describes these adverse events and recommends periodic patient monitoring.” Public Citizen officials say those warnings are not enough. “Public Citizen strongly believes that only a black box warning can adequately alert the remaining physicians prescribing combination therapy to its dangers,” Dr. Sammy Almashat, a researcher with Public Citizen’s Health Research Group, said in a press release. “Burying such a warning deep within the medications’ physician labels, as the FDA is currently doing, guarantees that hundreds of thousands of patients will continue to unknowingly be exposed to these preventable harms.” To date, the FDA only contraindicates against the use of aliskiren with either an ACE inhibitor or an ARB in diabetics, Public Citizen officials note. They also note that two ACE inhibitors, captopril and fosinopril, lack even this warning. Public Citizen officials say the FDA needs to also make the same contraindication against combining ACE inhibitors and ARBs. A black box label warning is the strongest label warning the FDA can require a drug to carry. ACE inhibitors and ARBs, like Benicar, losartan and lisinopril, are blood pressure medications that are often prescribed to help with kidney disease triggered by diabetes. They help lower blood pressure and reduce the amount of protein in the urine, often a sign of kidney damage. A study published in November 2013 in the New England Journal of Medicine found that combining the drugs does not help reduce end-stage kidney disease and actually can cause additional harm to kidneys. The study was halted in 2012 due to concerns about the frequency and degree of adverse side effects affecting the study’s 1,500 participants. While some patients saw a slight decrease in the progression of the disease, the change was not significant. Instead, a significant increase in serious side effects was seen. More study participants required hospitalizations, additional kidney treatments and symptoms of severe kidney injury. The combination group also faced an increased the risk of hyperkalemia, elevated levels of potassium in the blood. At extremely high levels, hyperkalemia can cause cardiac arrest and death. Benicar Sprue-Like Enteropathy The findings come as the makers of Benicar, one of the best-selling ARBs, face criticism over failure to adequately warn about the risk of intestinal side effects associated with the drug, including chronic diarrhea and other symptoms of a condition known as sprue-like enteropathy. Benicar (olmesartan medoxomil) is part of a family of Daiichi Sankyo hypertension drugs, which also includes Benicar HCT, Azor and Tribenzor. All of the blood pressure drugs include the active ingredient olmesartan, which has been linked to the development sprue-like enteropathy. As a result of the lack of warnings provided by the drug makers, many users have repeatedly been hospitalized with severe diarrhea, as doctors were unaware that the symptoms may be caused by their blood pressure medication. The Benicar problems have often been misdiagnosed as Celiac disease or unclassified sprue, resulting in continued use of the medication, which could leave users with long-term intestinal damage. Although the diarrhea symptoms associated with sprue-like enteropathy typically resolve when the medication is no longer used, the problems can cause permanent damage to the intestines, known as villous atrophy from Benicar. Daiich Sankyo and Forest Laboratories face a growing number of Benicar lawsuits by patients who say the companies failed to provide adequate warning of the risk of sprue-like enteropathy. Tags: ACE Inhibitors, Benicar, Daiichi Sankyo, Enteropathy, Forest Laboratories, Hypertension, Kidney Injury, Losartan, Sprue More Benicar Lawsuit Stories Benicar Recall Urged in FDA Petition Filed by Public Citizen December 8, 2017 Benicar Settlement to Result in $300M Payment By Drug Maker for Gastrointestinal Injuries August 1, 2017 Benicar Lawsuits Over Diarrhea, Gastrointestinal Problems Filed By Nearly 2,000 July 17, 2017 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 2 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 2 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 3 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
Benicar Settlement to Result in $300M Payment By Drug Maker for Gastrointestinal Injuries August 1, 2017
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 2 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 2 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 3 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)